Qualigen Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
618
across all filing types
Latest filing
2026-05-28
Regulatory Filings
Country
US
United States of America
Listing
US
QLGN
Qualigen Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company's efforts are directed toward creating therapeutics for both adult and pediatric patients, with a particular emphasis on rare cancers and areas of high unmet medical need. Its development approach combines internal capabilities with collaborations from major cancer research institutions. The company's investigational oncology pipeline includes programs such as QN-302, a Pan-RAS inhibitor platform, and QN-247.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-28 | English | |
| 8-K | 2026-05-14 | English | |
| 10-K - AIxCrypto Holdings, Inc. (0001460702) (Filer) | 2026-03-30 | English | |
| 8-K - QUALIGEN THERAPEUTICS, INC. (0001460702) (Filer) | 2026-02-27 | English | |
| 8-K Filing | 2026-02-17 | English | |
| 8-K Filing | 2026-02-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 47868643 | 8-K | 2026-05-28 | English | ||
| 46297048 | 8-K | 2026-05-14 | English | ||
| 33086731 | 10-K - AIxCrypto Holdings, Inc. (0001460702) (Filer) | 2026-03-30 | English | ||
| 32892109 | 8-K - QUALIGEN THERAPEUTICS, INC. (0001460702) (Filer) | 2026-02-27 | English | ||
| 29898613 | 8-K Filing | 2026-02-17 | English | ||
| 29898632 | 8-K Filing | 2026-02-02 | English | ||
| 29898563 | SCHEDULE 13G/A Filing | 2026-01-29 | English | ||
| 12272692 | 8-K | 2026-01-06 | English | ||
|
2025
7 filings
| |||||
| 12272693 | 8-K | 2025-12-16 | English | ||
| 12272694 | DEF 14A | 2025-12-15 | English | ||
| 12272698 | Regulatory Filings 2025 | 2025-12-12 | English | ||
| 12272700 | DEL AM | 2025-12-08 | English | ||
| 12272699 | OWNERSHIP DOCUMENT | 2025-12-06 | English | ||
| 12272697 | Director's Dealing 2025 | 2025-12-06 | English | ||
| 12272702 | S-1 | 2025-12-04 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHAMPIONS ONCOLOGY, INC.
A CRO providing end-to-end solutions to accelerate oncology…
|
CSBR | US | Professional, scientific and te… |
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
A contract research organization supporting drug discovery …
|
CRL | US | Professional, scientific and te… |
|
ChemPartner PharmaTech Co., Ltd.
Global CRO and CDMO providing integrated drug discovery and…
|
300149 | CN | Professional, scientific and te… |
|
CHIMERIC THERAPEUTICS LIMITED
Clinical-stage cell therapy company developing CAR T and NK…
|
CHM | AU | Professional, scientific and te… |
|
China National Electric Apparatus Research Institute Co., Ltd.
R&D institution for electrical and electronics testing, equ…
|
688128 | CN | Professional, scientific and te… |
|
Chiome Bioscience Inc.
Clinical-stage biotech company developing antibody-based th…
|
4583 | JP | Professional, scientific and te… |
|
CHITOGENX INC
Clinical stage regenerative medicine company focused on nov…
|
CHGX | CA | Professional, scientific and te… |
|
Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment fo…
|
CMH | SE | Professional, scientific and te… |
|
Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies ta…
|
190A | JP | Professional, scientific and te… |
|
Cibus, Inc.
Develops and licenses plant traits using non-GMO precision …
|
CBUS | US | Professional, scientific and te… |
Qualigen Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35251/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35251 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35251 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35251 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35251}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Qualigen Therapeutics, Inc. (id: 35251)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.